Results
2
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
2 companies
Philogen
Market Cap: €911.5m
A biotechnology company, develops drugs for oncology and chronic inflammatory diseases.
PHIL
€22.60
7D
0.9%
1Y
9.7%
Fine Foods & Pharmaceuticals N.T.M
Market Cap: €180.7m
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
€7.38
0%
-14.8%